1. United States Food and Drug Administration. Inapsine dear doc letter, December 4, 2001. Available at: http://www.fda.gov/medwatch/safety/2001/inapsine.htm. Accessed March 07, 2002.
2. FDA advisory panel discusses droperidol concerns;Young;Am J Health Syst Pharm,2004
3. American Regent Laboratories, Inc. Droperidol Injection, USP product insert. Reference number IN9702. Revised 1/02.
4. Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current;Drolet;J Cardiovasc Electrophysiol,1999
5. Droperidol, QT prolongation, and sudden death;Kao;Ann Emerg Med,2003